2011
DOI: 10.1007/s00115-010-3210-6
|View full text |Cite
|
Sign up to set email alerts
|

SIPS – Screening-Instrument für prämenstruelle Symptome*

Abstract: The SIPS is reliable and valid and may help to improve the identification of women who require treatment for their premenstrual symptoms.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
4

Year Published

2012
2012
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(8 citation statements)
references
References 22 publications
0
3
0
4
Order By: Relevance
“…The reasons for discontinuation of the study for the 19 subjects (12 controls, 7 women with PMS) who initially met eligibility but did not complete the entire protocol were the following: inconsistencies/lack of compliance with menstrual cycle reports or scheduling of assessments (12), decision to start oral contraceptives (4), positive pregnancy test (2), and an accident resulting in leg-fracture (1). Before entry into the study, prospective participants were screened using the German version of the premenstrual symptoms screening tool (PSST) [5], [35], which is a valid and reliable instrument for PMS/PMDD screening, and assigned to either the PMS group ( n  = 15) or the control group ( n  = 15). Demographic details of the subjects can be found in Table 1; groups were matched for degree of education, profession and parity.…”
Section: Methodsmentioning
confidence: 99%
“…The reasons for discontinuation of the study for the 19 subjects (12 controls, 7 women with PMS) who initially met eligibility but did not complete the entire protocol were the following: inconsistencies/lack of compliance with menstrual cycle reports or scheduling of assessments (12), decision to start oral contraceptives (4), positive pregnancy test (2), and an accident resulting in leg-fracture (1). Before entry into the study, prospective participants were screened using the German version of the premenstrual symptoms screening tool (PSST) [5], [35], which is a valid and reliable instrument for PMS/PMDD screening, and assigned to either the PMS group ( n  = 15) or the control group ( n  = 15). Demographic details of the subjects can be found in Table 1; groups were matched for degree of education, profession and parity.…”
Section: Methodsmentioning
confidence: 99%
“…After completing the informed consent form, all participants underwent a screening to control for inclusion and exclusion criteria including questionnaires regarding menstrual cycle and OC history, gynecological history (e.g., premenstrual syndrome-PSST; Bentz et al, 2012), pregnancies, endometriosis, polycystic ovary syndrome etc. ), verbal intelligence (WST; Schmidt and Metzler, 1992), executive functioning (TMT; Reitan, 1992) and the German version of the Structured Clinical Interview (SCID; Wittchen et al, 1997) to exclude a history of mental illness.…”
Section: Methodsmentioning
confidence: 99%
“…B. SCID-5-CV, SCID-PMMD) sowie geeignete Selbstfragebögen (z. B. PSST) ergänzt werden [ 15 17 ] (Abb. 2 ).…”
Section: Diagnostische Assessmentunclassified